Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 2 medicines
PHARMAC · 2 medicines
FDA · 2 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Every register, a page at a time. Strengths and packs are on each medicine’s page.
7 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Digifab | United States | 40MG | For Injection | Marketed | Salvagenix Inc. |
| Digifab | Canada | 40 MG / VIAL | Powder For Solution | Marketed | BTG International INC |
| Any | New Zealand | Inj 38 mg vial | Funded | ||
| Any | New Zealand | Inj 40 mg vial | Funded | ||
| Digitoxin | Taiwan | （粉） | Cancelled | 東信化學藥品有限公司 | |
| Digibind | United States | 38MG | For Injection | Withdrawn | Wellcome Foundation Limited Wellcome Research Laboratories |
| Digibind | Canada | 38 MG / VIAL | Powder For Solution | Cancelled | Glaxosmithkline INC |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of FDA, Health Canada and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
